Olema Pharmaceuticals, Inc. Marketable Securities, Current in USD from Q1 2021 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Olema Pharmaceuticals, Inc. quarterly Marketable Securities, Current history and growth rate from Q1 2021 to Q3 2025.
  • Olema Pharmaceuticals, Inc. Marketable Securities, Current for the quarter ending September 30, 2025 was $294M, a 64.2% increase year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)

Olema Pharmaceuticals, Inc. Quarterly Marketable Securities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $294M +$115M +64.2% Sep 30, 2025 10-Q 2025-11-10
Q2 2025 $309M +$87.2M +39.3% Jun 30, 2025 10-Q 2025-08-11
Q1 2025 $342M +$127M +58.9% Mar 31, 2025 10-Q 2025-05-13
Q4 2024 $295M +$101M +52.4% Dec 31, 2024 10-Q 2025-11-10
Q3 2024 $179M +$19.4M +12.2% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $222M +$89.7M +67.7% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $215M +$70.2M +48.4% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $193M +$12.5M +6.94% Dec 31, 2023 10-K 2025-03-18
Q3 2023 $159M -$36.3M -18.5% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $132M -$83.7M -38.7% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $145M -$101M -41.1% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $181M -$92.7M -33.9% Dec 31, 2022 10-K 2024-03-11
Q3 2022 $196M -$84.6M -30.2% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $216M -$51.5M -19.3% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $246M -$32.7M -11.7% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $273M Dec 31, 2021 10-K 2023-03-09
Q3 2021 $280M Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $268M Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $279M Mar 31, 2021 10-Q 2021-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.